Jillian Retallick Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 175 S Barfield Dr, Marco Island, FL 34145 Phone: 239-394-1220 |
Mrs. Mary Beth Meyer, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 175 S Barfield Dr, Marco Island, FL 34145 Phone: 239-394-1220 Fax: 239-394-2402 |
Kimberly Barry, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 320 Seaview Ct, Unit 2012, Marco Island, FL 34145 Phone: 239-389-1579 |
Christine Jandorf Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 676 Bald Eagle Dr, Marco Island, FL 34145 Phone: 239-394-4181 |
Heather Arroyave Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 625 N Collier Blvd, Marco Island, FL 34145 Phone: 239-393-0843 |
Oscar Ntoko Njume Jr. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1800 San Marco Rd, Marco Island, FL 34145 Phone: 239-394-5303 Fax: 239-394-5149 |
Dr. Rosemary Margaret Tecza, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 676 Bald Eagle Dr, Marco Island, FL 34145 Phone: 239-394-4181 |
Mr. Robert Albert Edgerton Jr., RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 625 N Collier Blvd, Marco Island, FL 34145 Phone: 239-393-0843 Fax: 239-642-9841 |
Jennifer Allison, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1800 San Marco Rd, Marco Island, FL 34145 Phone: 239-394-5303 |
Marlia Burke, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1757 San Marco Rd Unit B, Marco Island, FL 34145 Phone: 239-970-0415 Fax: 239-970-0649 |
Mr. Larry Gilbert Heine, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1089 N Collier Blvd, Marco Island, FL 34145 Phone: 239-394-3111 Fax: 239-394-8841 |
Travis Barry, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 625 N Collier Blvd, Marco Island, FL 34145 Phone: 239-393-0843 |
Dr. Nicole Kwilos, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1800 San Marco Rd, Marco Island, FL 34145 Phone: 239-394-5303 |
Dawnn Winge, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 175 S Barfield Dr, Marco Island, FL 34145 Phone: 239-394-1220 |
Michael Jeremy Hauser, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1100 N Collier Blvd, Marco Island, FL 34145 Phone: 239-389-2888 |
Mindy Russell, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1800 San Marco Rd, Marco Island, FL 34145 Phone: 419-461-6812 |
Dr. Summer Harrison Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 676 Bald Eagle Dr, Marco Island, FL 34145 Phone: 239-394-4181 |
Iris L Mayer Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 847 Old Marco Ln, Marco Island, FL 34145 Phone: 210-389-8790 Fax: 866-732-4121 |
Mrs. Carol Ann Bedinghaus, R PH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1089 N Collier Blvd, Marco Island, FL 34145 Phone: 239-394-3111 Fax: 239-394-8841 |
News Archive
Older age, being male, deprivation, living in a densely populated area, ethnicity, obesity, and chronic kidney disease are associated with a positive test for COVID-19, according to results from 3,802 people tested for SARS-CoV-2 (including 587 positive tests) in the UK.
Drugmaker Merck announced it is closing eight research centers and eight manufacturing plants and laying off 15,000 people from its worldwide operations during the next two years because of its merger with Schering-Plough. "The restructuring is expected to save $2.7 billion to $3.1 billion in 2012, the company said. Meanwhile, the pretax cost of the initial phase of the cost-cutting program is expected to range from $3.5 billion to $4.3 billion, much of it in severance packages for employees."
Whether non-smoking Mexican-American adolescents go on to experiment with smoking depends largely on their initial attitude toward the habit, researchers at M. D. Anderson Cancer Center report in the December issue of Cancer Epidemiology, Biomarkers and Prevention, a journal of the American Association for Cancer Research.
Roche today announced approval of the VENTANA PD-L1 (SP142) Assay by the US Food and Drug Administration as a complementary diagnostic to provide PD-L1 status on patients who are considering treatment with the FDA approved Roche immunotherapy TECENTRIQâ„¢ (atezolizumab) for metastatic urothelial cancer (mUC).
› Verified 1 days ago